Status:
COMPLETED
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy
Lead Sponsor:
Atos Medical AB
Collaborating Sponsors:
The Netherlands Cancer Institute
Conditions:
Total Laryngectomy
Eligibility:
All Genders
21+ years
Phase:
PHASE1
Brief Summary
This study is a short term feasibility study that aims to investigate patient satisfaction with and performance of new Provox Xtra HME in 20 laryngectomized patients. Aspects that are considered are f...
Eligibility Criteria
Inclusion
- total laryngectomy
- compliant Provox HME user (24/7 use)
Exclusion
- current medical problems that might influence HME use
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00942903
Start Date
July 1 2009
End Date
August 1 2009
Last Update
October 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066 CX